Literature DB >> 12601556

Molecular cloning and characterization of the protein 4.1O gene, a novel member of the protein 4.1 family with focal expression in ovary.

Xiaohua Ni1, Chaoneng Ji, Gentao Cao, Haipeng Cheng, Lingchen Guo, Shaohua Gu, Kang Ying, Robert C Zhao, Yumin Mao.   

Abstract

Protein 4.1 is an important structural protein that is expressed in erythroid and in a variety of nonerythroid tissues. In mammalian erythrocytes, it plays a key role in regulating the physical properties of mechanical stability and deformability in membranes by stabilizing the spectrin-actin interaction. The protein 4.1 family mainly comprises 4.1R, 4.1G (general type), 4.1B (brain type), and 4.1N (neuron type). We identified a novel human 4.1 ( 4.1O) gene that is 2312 bp in length and encodes a protein of 553 amino acid residues. The protein shared homology with mouse protein 4.1B (identity 38%, similarity 55%) with a FERM domain. The expression pattern of the human 4.1O gene in 16 tissues showed that there was a transcript only in ovary, whereas in the remaining 15 tissues, specific bands of the transcript could not be detected. In eight human fetal tissues, the specific bands of the transcript could be detected in skeletal muscle, with lower levels detected in thymus and brain. The 4.1O gene consists of 14 exons and 13 introns and was mapped to Chromosome 9q21-9q22 by bioinformatics analysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601556     DOI: 10.1007/s100380300015

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  13 in total

Review 1.  Genome-wide association studies of chronic kidney disease: what have we learned?

Authors:  Conall M O'Seaghdha; Caroline S Fox
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

Review 2.  Glomerular diseases: genetic causes and future therapeutics.

Authors:  Chih-Kang Chiang; Reiko Inagi
Journal:  Nat Rev Nephrol       Date:  2010-07-20       Impact factor: 28.314

3.  Interaction of 4.1G and cGMP-gated channels in rod photoreceptor outer segments.

Authors:  Christiana L Cheng; Robert S Molday
Journal:  J Cell Sci       Date:  2013-10-21       Impact factor: 5.285

4.  Increase in cell-surface localization of parathyroid hormone receptor by cytoskeletal protein 4.1G.

Authors:  Masaki Saito; Maki Sugai; Yuriko Katsushima; Teruyuki Yanagisawa; Jun Sukegawa; Norimichi Nakahata
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

5.  Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.

Authors:  Barry I Freedman; Carl D Langefeld; Lingyi Lu; Jasmin Divers; Mary E Comeau; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Randall C Johnson; Nicholette D Palmer; Pamela J Hicks; Meredith A Bostrom; Jessica N Cooke; Caitrin W McDonough; Donald W Bowden
Journal:  PLoS Genet       Date:  2011-06-16       Impact factor: 5.917

6.  Protein 4.1B contributes to the organization of peripheral myelinated axons.

Authors:  Carmen Cifuentes-Diaz; Fabrice Chareyre; Marta Garcia; Jérôme Devaux; Michèle Carnaud; Grégoire Levasseur; Michiko Niwa-Kawakita; Sheila Harroch; Jean-Antoine Girault; Marco Giovannini; Laurence Goutebroze
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

Review 7.  FRMD3 gene: its role in diabetic kidney disease. A narrative review.

Authors:  Marjoriê Piuco Buffon; Denise Alves Sortica; Fernando Gerchman; Daisy Crispim; Luís Henrique Canani
Journal:  Diabetol Metab Syndr       Date:  2015-12-30       Impact factor: 3.320

8.  rs1888747 polymorphism in the FRMD3 gene, gene and protein expression: role in diabetic kidney disease.

Authors:  Marjoriê P Buffon; Mariana P Carpena; Denise A Sortica; Andressa Santer; Rodrigo Carlessi; Bianca M de Souza; Maria I Edelweiss; Milton Berger; Daisy Crispim; Luís H Canani
Journal:  Diabetol Metab Syndr       Date:  2016-01-08       Impact factor: 3.320

9.  Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.

Authors:  Marcus G Pezzolesi; G David Poznik; Josyf C Mychaleckyj; Andrew D Paterson; Michelle T Barati; Jon B Klein; Daniel P K Ng; Grzegorz Placha; Luis H Canani; Jacek Bochenski; Daryl Waggott; Michael L Merchant; Bozena Krolewski; Lucia Mirea; Krzysztof Wanic; Pisut Katavetin; Masahiko Kure; Pawel Wolkow; Jonathon S Dunn; Adam Smiles; William H Walker; Andrew P Boright; Shelley B Bull; Alessandro Doria; John J Rogus; Stephen S Rich; James H Warram; Andrzej S Krolewski
Journal:  Diabetes       Date:  2009-02-27       Impact factor: 9.461

10.  High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT.

Authors:  Tzu-Ju Chen; Chia-Lin Chou; Yu-Feng Tian; Cheng-Fa Yeh; Ti-Chun Chan; Hong-Lin He; Wan-Shan Li; Hsin-Hwa Tsai; Chien-Feng Li; Hong-Yue Lai
Journal:  Int J Clin Oncol       Date:  2021-05-27       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.